Briones-Garduño JC , Díaz de León-Ponce M, González-Vargas A, Briones-Vega CG

Language: Spanish
References: 13
Page: 112-115
PDF size: 36.66 Kb.

ABSTRACT

Introduction: Conservative treatment in severe preeclampsia has been documented by several authors citing significant improvement in neonatal outcome lacking a significant increase in maternal complications. Objective: Our objective was to inform of our preliminary results using protocolized conservative management in women with preeclampsia-eclampsia, favoring better neonate conditions. Material and patients: We included 34 patients with ave-rage age of 28.2 years with documented severe preeclampsia-eclampsia complicating a 36-weeks or less pregnancy, admitted in the obstetric intensive care unit (OICU) between October 2001 and February 2002. Patients received protocolized management consisting of intravascular colume expansion, anti-hypertensive control, target organ protection, monitoring, and clinical observation. We considered conservative management as a 24 or more period offered to patients with satisfactory response to medical treatment and no evidence of binomial compromise. Results: Of our group, 85% corresponded to severe preeclampsia, 9% to eclampsia, 3% to imminence of eclampsia, and 3% to HELLP syndrome. Average stay in OICU was 5.5 days with 3.5 days average management before pregnancy was interrupted. These patients presented mean gestational age of 32.8 weeks during which we observed anemia, low platelets, D dimmer increments, MAP average of 112.8, PCOc 18.6, and BI 0.15. We obtained 36 live newborns of whom 12% four died, two were extremely immatures (510 g and 600 g, respectively); one 980-g newborn presented intraventricular hemorrhage, and a 1,450-g newborn had multiple organ failure. Conservative treatment in patients with severe preeclampsia-eclampsia is a feasible alternative in hospitals with an ICU. Conservative management can improve neonatal survival and prognosis in preterm newborns.

REFERENCES

1. Odendall HJ, Pattinson C, et al. Aggressive or expectant management for patients with severe preeclampsia between 28-34 weeks of gestation: a randomized controlled trial. Obstet Gynecol 1990;76: 1070-1074.

2. Sibai BM, Brian NM, et al. Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks of gestation. A randomized controlled trial. Am J Obstet Gynecol 1994;171:818-822.

3. Romero AJF, Lara GAL, Izquierdo PC. Manejo conservador en preeclampsia severa. Ginec Obst Mex 2000;68:51-54.

4. Schiff E, Sibai BM. Conservative management of severe preeclampsia remote from term. Obstet Gynecol 1994;84:626-630.

5. Sibai BM, Sherif A, et al. A protocol for managing severe preeclampsia in the second trimester. Am J Obstet Gynecol 1990;163:733-738.

6. Sibai BM, Abdella TN, Spinato JA, Anderson GD. Eclampsia. The incidence of nonpreventable eclampsia. Am J Obstet Gynecol 1986;145(3):581-586.

7. López Llera MM, Díaz de León PM, Rodríguez AJ, Ayala RA. Preeclampsia- eclampsia un problema médico diferido. Gac Med Mex 1999;135(4):397-405.

8. Velazco MN, Navarrete HE, Cardona PJA, Madrazo NM. Mortalidad materna por preeclampsia-eclampsia en el Instituto Mexicano del Seguro Social 1987-1996. Rev Med IMSS 1997;35(6):451-456.

9. Briones GJC, Espinosa LF. ¿La terapia intensiva especializada abatirá la mortalidad materna? Rev Med IMSS 1999;37(4):253-255.

10. Briones GJC, Díaz de León PM, Gómez Bravo TE, Ávila EF, Briones VCG, Urrutia TF. Protocolo de manejo en la preeclampsia eclampsia. Estudio comparativo. Cir Ciruj 1999;67:4-10.

11. Gómez Bravo TE, Briones GJC, Díaz de León PM, Ávila EF, Briones VCG. Frotis de sangre periférica y alteración orgánica en la preeclampsia eclampsia. Cir Ciruj 2000;68:159-163.

12. Briones GJC, Díaz de León PM, Gómez Bravo TE, Ávila EF, Ochoa REC, Briones VCG, Urrutia TF. Medición de la fuga capilar en la preeclampsia eclampsia. Cir Ciruj 2000;68:194-197.

13. Gómez Bravo TE, Briones GJC, Castañón GJA, Díaz de León PM, Morales EJG, Briones VCG. Medicina crítica en obstetricia. Impacto de un programa educativo. Rev Asoc Mex Med Crit Ter lnt 2001;15(4):126-129.